Physician profile
Robert O Northway
NPI 1982657367
$5,952.44
in general payments reported to CMS, 2019-2025
48 companies · $958 in 2025
The $958 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $693 · 2020: $584 · 2021: $1,203 · 2022: $775 · 2023: $701 · 2024: $1,039 · 2025: $958.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,694 · Education: $4.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,693.52 |
| Education | $4.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $824.96 | 2019-2025 | |
| Astellas Pharma US INC | $700.01 | 2019-2024 | Xtandi, Myrbetriq |
| Pfizer INC. | $656.05 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $534.66 | 2023-2025 | Orgovyx, Gemtesa |
| Boston Scientific Corporation | $278.78 | 2019-2024 | Ams 700, Ams 800 Artificial Urinary Sphincter |
| Janssen Biotech, INC. | $272.68 | 2019-2025 | Erleada |
| Dendreon Pharmaceuticals LLC | $194.78 | 2019-2025 | Provenge |
| Allergan, INC. | $179.84 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $167.36 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $143.29 | 2021-2025 | Lynparza, Keytruda |
| Myovant Sciences INC. | $128.64 | 2021-2022 | |
| Amgen INC. | $119.14 | 2019-2021 | |
| Olympus America INC. | $118.23 | 2024-2025 | Itind System |
| Ferring Pharmaceuticals INC. | $107.77 | 2019-2025 | Adstiladrin |
| Sun Pharmaceutical Industries INC. | $107.75 | 2019-2025 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Northway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.